Is there a better way to wean chronic benzodiazepine receptor agonists use by substituting a DORA (and starting CBT-I)?
作者信息
Grigg-Damberger Madeleine
机构信息
Department of Neurology, University of New Mexico School of Medicine, Albuquerque, New Mexico.
出版信息
J Clin Sleep Med. 2024 Apr 1;20(4):483-485. doi: 10.5664/jcsm.11058.
Abstract
摘要
相似文献
1
Is there a better way to wean chronic benzodiazepine receptor agonists use by substituting a DORA (and starting CBT-I)?
J Clin Sleep Med. 2024 Apr 1;20(4):483-485. doi: 10.5664/jcsm.11058.
2
GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam.
CNS Drugs. 2012 Mar 1;26(3):229-44. doi: 10.2165/11599020-000000000-00000.
3
Care coordination needs for deprescribing benzodiazepines and benzodiazepine receptor agonists.
Res Social Adm Pharm. 2022 Apr;18(4):2691-2694. doi: 10.1016/j.sapharm.2021.06.025. Epub 2021 Jul 1.
4
Behavioral effects of GABA agonists in relation to anxiety and benzodiazepine action.
Life Sci. 1987 Jun 22;40(25):2429-36. doi: 10.1016/0024-3205(87)90758-2.
5
The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control Study.
Sleep. 2015 Jul 1;38(7):1045-50. doi: 10.5665/sleep.4808.
6
Palatability-dependent appetite and benzodiazepines: new directions from the pharmacology of GABA(A) receptor subtypes.
Appetite. 2005 Apr;44(2):133-50. doi: 10.1016/j.appet.2005.01.003.
7
Increased brain concentrations of endogenous (non-benzodiazepine) GABA-A receptor ligands in human hepatic encephalopathy.
Metab Brain Dis. 2004 Dec;19(3-4):241-51. doi: 10.1023/b:mebr.0000043974.89820.22.
8
Consequences of benzodiazepine receptor occupancy.
Neuropharmacology. 1983 Dec;22(12B):1493-8. doi: 10.1016/0028-3908(83)90117-x.
9
[GABA(A) benzodiazepine receptors and epilepsy].
Wien Klin Wochenschr. 1990 Mar 30;102(7):197-201.
10
Deprescribing benzodiazepine receptor agonists for insomnia in older adults.
Lancet. 2023 Oct 21;402(10411):1421-1422. doi: 10.1016/S0140-6736(23)01562-3.
本文引用的文献
1
Relationships of Hypnotics with Incident Dementia and Alzheimer's Disease: A Longitudinal Study and Meta-Analysis.
J Prev Alzheimers Dis. 2024;11(1):117-129. doi: 10.14283/jpad.2023.78.
2
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.
Ment Health Clin. 2023 Oct 2;13(5):244-254. doi: 10.9740/mhc.2023.10.244. eCollection 2023 Oct.
3
A retrospective clinical practice study comparing the usefulness of dual-orexin receptor antagonists and a melatonin receptor agonist in patients switching from long-term benzodiazepine receptor agonists.
J Clin Sleep Med. 2024 Apr 1;20(4):603-613. doi: 10.5664/jcsm.10946.
4
Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis.
Sleep. 2024 Feb 8;47(2). doi: 10.1093/sleep/zsad293.
5
Chronic Insomnia Disorder across Europe: Expert Opinion on Challenges and Opportunities to Improve Care.
Healthcare (Basel). 2023 Feb 28;11(5):716. doi: 10.3390/healthcare11050716.
6
Beliefs about prescription sleep medications and interest in reducing hypnotic use: an examination of middle-aged and older adults with insomnia disorder.
J Clin Sleep Med. 2023 Jul 1;19(7):1247-1257. doi: 10.5664/jcsm.10552.
7
Sleep Medication Use in Adults Aged 18 and Over: United States, 2020.
NCHS Data Brief. 2023 Jan(462):1-8.
8
Effect of discontinuation of lemborexant following long-term treatment of insomnia disorder: Secondary analysis of a randomized clinical trial.
Clin Transl Sci. 2023 Apr;16(4):581-592. doi: 10.1111/cts.13470. Epub 2023 Jan 6.
9
Hypnotic Discontinuation in Chronic Insomnia.
Sleep Med Clin. 2022 Sep;17(3):523-530. doi: 10.1016/j.jsmc.2022.06.014.
10
Z-drugs and Falls: A Focused Review of the Literature.
Sr Care Pharm. 2020 Dec 1;35(12):549-554. doi: 10.4140/TCP.n.2020.549.
Zotero 插件